With over 7,000 new medicines in development, we won't rest until everyone affected by disease can look forward to a brighter tomorrow.
With 10 million people a year projected to die from antibiotic-resistant infections by 2050, it’s important that all partners, including the pharmaceutical industry, step up and work together to tackle this issue.
“I won’t rest until we manage to deliver solutions that make blood cancer a manageable or even curable condition.” - Dr Catherine Taylor, Therapy Area Lead; Haemotology; Janssen Oncology; Europe, Middle East, Africa.
Have you ever wondered if the scientists you see in movies that are racing against the clock to prevent a deadly disease breakout actually exist?
Genomics is already delivering precision treatments to patients with remarkable speed: the landscape of life sciences is changing and it’s being driven by information.